To The Moon

$ESPORTS ENTERTAINMENT GRP(GMBL)$  This to me is bull😛, the profit is way over $352 actually.......

$iShares 20+ Year Treasury Bond ETF(TLT)$  $iShares 0-3 Month Treasury Bond ETF(SGOV)$  US Bond has been incredibly volatile the past 5 weeks. Signs of unrest in the debt market ? US 10-year bond yield has risen by 230bps since the beginning of last year, a sizeable increase by historical standards. Lately, the increase has also been accompanied by considerable volatility.  Just in the last five weeks, yields have risen and fallen by nearly 50bps in each direction. Signs of worrisome unrest in the world’s largest debt market?

The first and second reason for rates volatility are inter-related. US Federal Reserve’s policy rate hikes and quantitative tightening programs have, over the past yea

$Tesla Motors(TSLA)$  Tesla, the world’s EV leader, and legacy automakers that had been spending at breakneck speeds to build their electric car businesses, are now taking a more cautious approach to investments. The Tesla stock price gained 0.664% on the last trading day (Friday, 3rd Nov 2023), rising from $218.51 to $219.96. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.65% from a day low at $218.40 to a day high of $226.37. The price has risen in 7 of the last 10 days and is up by 3.76% over the past 2 weeks. Volume fell on the last day by -5 million shares and in t

$CN Energy Group Inc.(CNEY)$  Best Material Stocks Gainers Gold Fields (NYSE:GFI) shares increased by 7.7% to $14.2 during Friday's pre-market session. The company's market cap stands at $12.6 billion. Harmony Gold Mining Co (NYSE:HMY) shares rose 6.48% to $4.76. The company's market cap stands at $2.9 billion. McEwen Mining (NYSE:MUX) stock increased by 5.22% to $7.65. The company's market cap stands at $363.1 million. Hecla Mining (NYSE:HL) shares rose 5.19% to $3.85. The company's market cap stands at $2.3 billion. Anglogold Ashanti (NYSE:AU) stock rose 5.18% to $19.69. The company's market cap stands at $8.2 billion. DRDGold (NYSE:DRD) stock rose 5.17% to $8.95. The market value of their outstanding shares is at $770.3 million. Losers Tan

$Kosmos(KOS)$  It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad. In contrast to all that, many investors prefer to focus on companies like Kosmos Energy (NYSE:KOS), which has not only revenues, but also profits. Even if this company is fairly valued by the market, investors would agree that generating consistent profits will continue to provide Kosmos Energy

$GeoVax Labs Inc(GOVX)$  As world embraces again for new variants of COVID, Geovax Labs will be at forefront of medical breakthroughs!

$MICROMOBILITY.COM(MCOM)$  Shared micromobility company Helbiz said it will do a reverse stock split in an attempt to get back into compliance with the Nasdaq, which issued the company a delisting notice last July because its stock was trading too low. Helbiz is also rebranding to Micromobility.com Inc. to position itself as a micromobility brand that offers retail, rentals, shared micromobility, and *checks notes* sports streaming services. The rebrand comes alongside the launch of a new brick-and-mortar retail business, which will include the setting up of physical stores across the U.S., starting with its first store in SoHo, New York City in the next 60 days. There’s also an e-commerce site up today, featuring a small selection of e-scoot

$Cirrus Logic(CRUS)$  Cirrus Logic, Inc. (NASDAQ: CRUS) Market Cap: 4.939B Beta: 0.99 P/E Ratio: 15.03 Stop-loss: $103.95 (-4.27%) How to Buy CRUS stock? Learn more here. The price has been going up and down for this period, and there has been a 7.32% gain over the last 2 weeks. On Feb 03, 2023, Needham announced that it maintains CRUS, giving the stock a buy rating. A new price target of $110.00 is set. In general, the stock tends to have very controlled movements, and with good liquidity, the risk is considered very low in CRUS stock. 

$Gold.com(GOLD)$   Key Points Of The Global Stock Market News U.S. markets retreat on tariff escalation risk: Wall Street futures slid sharply as President Donald Trump threatened escalating tariffs on European allies over Greenland, reviving trade uncertainty and pressuring global equities ahead of a heavy earnings week. Europe faces renewed trade shock: Trump widened tariff threats by floating 200% duties on French wines and champagne, intensifying transatlantic tensions and raising the risk of retaliation that could weigh on European exports and consumer prices. Japan heads into high-stakes snap election: Prime Minister Sanae Takaichi called an early vote to lock in strong personal approval ratings, a move t

$Warner Bros. Discovery(WBD)$   $Paramount Global(PARAP)$   $Netflix(NFLX)$   Shares in Paramount Skydance fall after reports that the company's leadership is courting European regulators as part of its bid to acquire Warner Bros. Discovery. Paramount leadership met with French President Emmanuel Macron and European regulators in recent days, Bloomberg reports. Meanwhile, the company's chief executive, David Ellison, met with U.K. culture minister Lisa Nandy , according to Deadline. Any deal to buy Warner would require regulatory approval from the EU and the U.K. The reports come after a U.S. court yesterday

$Genprex, Inc.(GNPX)$   The Genprex Inc. stock price gained 19.58% on the last trading day (Wednesday, 14th Jan 2026), rising from $2.40 to $2.87. During the last trading day the stock fluctuated 36.67% from a day low at $2.10 to a day high of $2.87. The price has risen in 7 of the last 10 days and is up by 63.07% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $5.71 million. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to th

$Genprex, Inc.(GNPX)$   The Genprex Inc. stock price gained 19.58% on the last trading day (Wednesday, 14th Jan 2026), rising from $2.40 to $2.87. During the last trading day the stock fluctuated 36.67% from a day low at $2.10 to a day high of $2.87. The price has risen in 7 of the last 10 days and is up by 63.07% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $5.71 million. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to t

$NVIDIA(NVDA)$   High-Correlation Event NVIDIA-Eli Lilly $1B AI Drug Discovery Lab Impact Summary: Short-term: Neutral-to-positive sentiment (93% forum bullishness) may counter CES-driven declines, but market greed phase (Fear & Greed Index: 60.19) increases volatility sensitivity. Long-term: High-potential diversification into AI-driven drug discovery, enhancing NVIDIA's ecosystem beyond core chips via BioNeMo adoption. Risk: Regulatory scrutiny in healthcare AI and execution challenges in biotech integration remain unmonitored variables. Medium-Correlation Event CES Announcement Reaction & Market Sentiment Integrated Impact: Combined with high-correlation events, short-term pressure from underwhelming

$Genprex, Inc.(GNPX)$  Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex's oncology program utilizes its systemic, non-viral Oncoprex® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The resultant product is

$Alphabet(GOOG)$   Alphabet stock on Tuesday extended its record-breaking run having well and truly joined the $4 trillion club Monday, underlining the Google parent’s status as the market’s new artificial-intelligence darling. Alphabet’s Class A shares, which trade under the ticker GOOGL, rose 1.2% to $335.97, notching a five-day winning streak. The stock closed up 1% at a new high of $331.86 the previous session after Apple and Google said they had formed an AI partnership, which lifted Alphabet’s total market capitalization past $4 trillion for the first time ever.

$NVIDIA(NVDA)$   Summary Of AI Boom Cautiousness The AI Narrative that has powered the rally in the markets for the past three years has equities in extreme valuation territory. The huge surge in tech spending has powered 20%-plus EPS growth from the Magificent Seven while the rest of the market has seen tepid profit growth. This is projected to change for the positive in 2026 and 2027, potentially broadening market breadth. However, there are many potential sources for the trigger that eventually pops the AI Bubble. The article below discusses several of these potential triggers in detail and concludes with the most likely event that will result in a bear market following the AI Boom. In addition, there has bee

$Trump Media & Technology(DJT)$   $E-mini Dow Jones - main 2603(YMmain)$   The Dow Jones Industrial Average clawed back to close at a record 49,590.2, up 0.2% for the day. The S&P 500 notched another all-time high at 6,977.3, gaining 0.2%, while the Nasdaq Composite surged 0.3% to 23,733.9. And guess what? On January 13, the S&P 500 held steady around 6,977, showing resilience even as volatility simmers. Foreign investors aren't panicking—they're snapping up U.S. bonds like hotcakes, with Treasury auctions drawing massive demand. The 10-year yield stabilized at about 4.18%, signaling confidence in America's economic bac

$Genprex, Inc.(GNPX)$   Genprex (GNPX) technical analysis shows mixed signals, with some indicators suggesting overbought conditions (high RSI) and potential for pullbacks, while others, like moving averages, lean towards buys or neutral, with recent price volatility and high interest, but also potential for correction after big jumps, indicating range-bound trading or high risk for short-term swings. Predictions vary, with AI forecasting lower average prices in early 2026, and analysts seeing strong fundamentals but sideways trading. Key Technical Indicators (as of late 2025/early 2026 data): RSI (Relative Strength Index): Often indicates overbought (e.g., 75.834), suggesting a potential pullback. MACD: Mixed s